study

Hydroxychloroquine did not lead to faster symptom improvement among patients who had Covid-19 symptoms and were not hospitalized, according to a new study published Thursday in the Annals of Internal Medicine. The study, a randomized controlled trial led by researchers at the University of Minnesota, adds to the evidence that the malaria drug, heralded as…

Share on PinterestNew research indicates causality between high rates of pollution and premature death.New research has provided further evidence that exposure to fine air particulates causes an increased risk of premature death.The research, published in the journal Science Advances, indicates that strengthening the current air pollution standards in the United States could save the lives…

This 2020 electron microscope made available by the U.S. Centers for Disease Control and Prevention image shows the spherical coronavirus particles from the first U.S. case of COVID-19. (C.S. Goldsmith, A. Tamin/CDC via AP)OAN Newsroom UPDATED 1:18 PM PT —Saturday, July 11, 2020A new study has discovered more about the effects of COVID-19 on the…

The antimalarial drug hydroxychloroquine. /VCG The antimalarial drug hydroxychloroquine. /VCG The antimalarial drug hydroxychloroquine, which was touted by U.S. President Donald Trump, was found effective in treating COVID-19 patients by a new study after many others said no.The study, led by a research team from Henry Ford Health System in southeast Michigan, U.S., was published…

(Dennis Gleiss/Getty Images) CLAIRE CROSSAN, THE CONVERSATION 29 JUNE 2020 The novel coronavirus – SARS-CoV-2 – may have been in Europe for longer than previously thought. Recent studies have suggested that it was circulating in Italy as early as December 2019. More surprisingly, researchers at the University of Barcelona found traces of the virus when…